Cargando…
P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429428/ http://dx.doi.org/10.1097/01.HS9.0000969188.48112.10 |
| _version_ | 1785090710735683584 |
|---|---|
| author | Gat, Roi Neeman, Miri Levi, Shai Levi, Mor Eilati, Nili Bronstein, Yotam Shragai, Tamir Neuman, Tsipora Segman, Yafit Vitkon, Roy Mittelman, Moshe Avivi, Irit Moshe, Yakir |
| author_facet | Gat, Roi Neeman, Miri Levi, Shai Levi, Mor Eilati, Nili Bronstein, Yotam Shragai, Tamir Neuman, Tsipora Segman, Yafit Vitkon, Roy Mittelman, Moshe Avivi, Irit Moshe, Yakir |
| author_sort | Gat, Roi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429428 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104294282023-08-17 P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS Gat, Roi Neeman, Miri Levi, Shai Levi, Mor Eilati, Nili Bronstein, Yotam Shragai, Tamir Neuman, Tsipora Segman, Yafit Vitkon, Roy Mittelman, Moshe Avivi, Irit Moshe, Yakir Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429428/ http://dx.doi.org/10.1097/01.HS9.0000969188.48112.10 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Gat, Roi Neeman, Miri Levi, Shai Levi, Mor Eilati, Nili Bronstein, Yotam Shragai, Tamir Neuman, Tsipora Segman, Yafit Vitkon, Roy Mittelman, Moshe Avivi, Irit Moshe, Yakir P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS |
| title | P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS |
| title_full | P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS |
| title_fullStr | P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS |
| title_full_unstemmed | P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS |
| title_short | P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS |
| title_sort | p571: outpatient initiation of venetoclax-azacitidine for selected acute myeloid leukemia patients is feasible and safe: a real world single center analysis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429428/ http://dx.doi.org/10.1097/01.HS9.0000969188.48112.10 |
| work_keys_str_mv | AT gatroi p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT neemanmiri p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT levishai p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT levimor p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT eilatinili p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT bronsteinyotam p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT shragaitamir p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT neumantsipora p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT segmanyafit p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT vitkonroy p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT mittelmanmoshe p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT aviviirit p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis AT mosheyakir p571outpatientinitiationofvenetoclaxazacitidineforselectedacutemyeloidleukemiapatientsisfeasibleandsafearealworldsinglecenteranalysis |